Drug
Telavancin clinical trials
Also written VIBATIV and TD-6424.
Keep track of what changes. Save the telavancin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 5
Cumberland Pharmaceuticals (10) · M.D. Anderson Cancer Center (1) · Joseph L. Kuti, PharmD (1) · University of Michigan (1) · University of Illinois at Chicago (1) · Aaron Cook (1)
Studies
Open first, then newest update. How each study uses telavancin is read from its arms, and is right about nine times in ten.
Testing it · 15
- Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular DrainageRecruitingPhase 4Aaron CookNCT06119061Written as Telavancin Injection
- Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)TerminatedPhase 1Cumberland PharmaceuticalsNCT02013141Written as Telavancin
- A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialTerminatedPhase 3Cumberland PharmaceuticalsNCT02208063Written as Telavancin
- Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer PatientsCompletedPhase 2M.D. Anderson Cancer CenterNCT01321879Written as Telavancin
- Telavancin Pharmacokinetics in Cystic Fibrosis PatientsCompletedPhase 4Joseph L. Kuti, PharmDNCT03172793Written as Telavancin Injection
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00124020Written as Telavancin
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00091819Written as Telavancin
- Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedPhase 2Cumberland PharmaceuticalsNCT00077675Written as Telavancin
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00107952Written as Telavancin
- Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedPhase 2Cumberland PharmaceuticalsNCT00061633Written as Telavancin
- Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaCompletedPhase 2Cumberland PharmaceuticalsNCT00062647Written as Telavancin
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00107978Written as Telavancin
- A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinCompletedPhase 1Cumberland PharmaceuticalsNCT01238796Written as telavancin
- Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5CompletedPhase 4University of MichiganNCT02392208Written as Telavancin
- Pharmacokinetics of Telavancin in Normal and Obese SubjectsCompletedPhase 1University of Illinois at ChicagoNCT02753855Written as Telavancin
Codes
What other systems call telavancin · ClinicalTrials.gg INT004664
- MeSH (NLM) C487637telavancinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) XK134822Z0TELAVANCINConfirmed FDA, NLM, Wikidata
- RxNorm 473837Confirmed FDA, Wikidata
- Wikidata Q7695658telavancinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87603TelavancinOne source FDA
- DrugBank DB06402One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C487637 | telavancin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | XK134822Z0 | TELAVANCIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 473837 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7695658 | telavancin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87603 | Telavancin | One source FDA |
| DrugBank | DB06402 | — | One source Wikidata |
Also registered as telavancin hydrochloride (UNII 0701472ZG0 · RxNorm 864624).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.